Dr. Mamah Announced the 2021 Recipient of the Dr. John M. Anderson Excellence in Mental Health Award
Dr. Daniel Mamah was announced as this year’s recipient of the 2021 Dr. John M. Anderson Excellence in Mental Health Award. The St. Louis County Children’s Service Fund honors a mental healthcare professional each year who has made significant contributions in the field of behavioral health. Dr. John M. Anderson was an African American psychiatrist […]
Laughing gas relieves symptoms in people with treatment-resistant depression (Links to an external site)
Researchers at Washington University School of Medicine in St. Louis and the University of Chicago have found that a single, one-hour treatment that involves breathing in a mixture of oxygen and the anesthetic drug nitrous oxide — otherwise known as laughing gas — can significantly improve symptoms in people with treatment-resistant depression.
Finding a possible early treatment for COVID-19 in a 40-year-old antidepressant (Links to an external site)
Sharyn Alfonsi reports on the unusual path fluvoxamine, a drug commonly used to treat obsessive-compulsive disorder, has had to becoming an early treatment candidate for COVID-19
Fluvoxamine may prevent serious illness in COVID-19 patients (Links to an external site)
Antidepressant drug repurposed for patients with coronavirus infection
Barch, Bateman elected to National Academy of Medicine (Links to an external site)
Research into psychological disorders, Alzheimer’s disease earned the two one of the most prestigious honors in health, medical field
Pandemic is influencing perinatal/postpartum depression, anxiety (Links to an external site)
Fear of contracting or spreading COVID-19 might be increasing the severity of these symptoms, notes Dr. Cynthia Rogers.
Nasal Spray Is A New Antidepressant Option For People At High Risk of Suicide (Links to an external site)
The Food and Drug Administration has approved a variant of the anesthetic and party drug ketamine for suicidal patients with major depression.
2 Psychiatry Faculty Receive 2020 Achievement Awards (Links to an external site)
Joan Luby, MD, director of the School of Medicine’s Early Emotional Development Program and the Samuel and Mae S. Ludwig Professor of Child Psychiatry, will receive the Carl and Gerty Cori Faculty Achievement Award. Douglas F. Covey, the Andrew C. and Barbara B. Taylor Distinguished Professor of Psychiatry at the School of Medicine, will receive […]
Can an antidepressant stop COVID-19’s deadly ‘cytokine storm’? (Links to an external site)
Researchers in St. Louis have launched a study into whether a long-used antidepressant can reduce the likelihood that COVID-19 will turn deadly.
Wash U to test OCD drug for potential COVID-19 treatment
Researchers at Washington University School of Medicine are recruiting COVID-19 patients for a clinical trial that will examine whether an existing anti-depressant can be an effective treatment for COVID-19.
WUSM to break ground on major neuroscience research hub (Links to an external site)
Washington University in St. Louis will begin construction in March on what will be one of the largest neuroscience research buildings in the country.
New antidepressants on horizon (Links to an external site)
Neuroactive steroid drugs result from Taylor Family Institute, pharma collaboration